
New Deep Learning Tool Enhances Precision in Cancer Treatment
New deep learning tool, Flexynesis, improves cancer treatment precision by analyzing multi-omics data and medical images. π§¬π»
Discover the newest research about AI innovations in π€ Personalized Medicine.

New deep learning tool, Flexynesis, improves cancer treatment precision by analyzing multi-omics data and medical images. π§¬π»

AI and Oral Microbiome: Transforming Early Detection of Oral Cancer π¦·π€

Machine learning predicts cancer patient mortality dynamics, revealing three clinical patterns and key lab parameters. ππ‘

New AI tools from Penn enhance kidney disease treatment by analyzing cellular data for personalized therapies. π§¬π

Plasma proteomics reveals four sepsis subtypes, with Cluster 0 showing 100% mortality. Key for personalized therapies! β οΈπ¬

Exploring biomarkers in high-risk prostate cancer: 50-75% relapse rate post-treatment. Genomic profiling enhances precision oncology. ππ¬

AI-driven reverse docking revolutionizes drug discovery, enhancing target identification and repurposing. Key insights from PubMed review. ππ€

AI reveals critical genes in pediatric high-grade gliomas, enhancing precision therapy strategies for tumor plasticity and aggressiveness. π§ π¬

Neural networks predict knee osteoarthritis progression with 0.913 AUC accuracy using MRI radiomics and biomarkers. ππ¦΅

Exploring healthcare tech: AI, robotics, telemedicine, and blockchain transform patient care. ππ€π»